oa Delta variant of COVID-19: A simple explanation

References

1. Aleem A, Akbar Samad AB, Slenker AK. Emerging variants of SARS-CoV-2 and Novel Therapeutics against coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2021 June 29:2021 Jan–. PMID: 34033342.
   [Google Scholar]
2. Callaway E. Delta coronavirus variant: scientists brace for impact. Nature 2021; 595:(7865):17–18. doi: 10.1038/d41586-021-01696-3 .
   [Google Scholar]
3. Center for Disease Control and Prevention. About variants of the virus that causes COVID-19. Available from https://www.cdc.gov/coronavirus/2019-ncov/variants/variant.html. Accessed August 1, 2021.
   [Google Scholar]
4. The effects of virus variants on COVID-19 vaccines. Available from https://www.who.int/news-room/feature-stories/detail/the-effects-of-virus-variants-on-covid-19-vaccines?gclid = CjwKCAjwxo6IBhBKEiwAXSYBs4MWI6j9EmfBp8PvAJ0tCKavdWGqlc0Yucv7TL_bLiO3ZZWTr2B8rhoCGsUQAvD_BwE. Accessed July 30, 2021. World Health Organization.
5. Sender R, Bar-On YM, Gleizer S, et al. The total number and mass of SARS-CoV-2 virions in an infected person [preprint]. medRxiv 2020:2020.11.16.20232009. doi: 10.1101/2020.11.16.20232009 .
   [Google Scholar]
6. Hendaus MA. Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary. J Biomol Struct Dyn 2021; 39:(10):3787–3792. doi: 10.1080/07391102.2020.1767691 .
   [Google Scholar]
7. Hendaus MA, Jomha FA. mRNA vaccines for COVID-19: A simple explanation. Qatar Med J 2021; 2021:(1):07. doi: 10.5339/qmj.2021.07 .
   [Google Scholar]
8. Hendaus MA, Jomha FA. Covid-19 induced superimposed bacterial infection. J Biomol Struct Dyn 2021; 39:(11):4185–4191. doi: 10.1080/07391102.2020.1772110 .
   [Google Scholar]
9. Hendaus MA, Jomha FA. From COVID-19 to clot: the involvement of the complement system [published online ahead of print, October 16 2020]. J Biomol Struct Dyn 2020:1–6. doi: 10.1080/07391102.2020.1832919 .
   [Google Scholar]
10. Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 2020; 41:(9):1141–1149. doi: 10.1038/s41401-020-0485-4 .
    [Google Scholar]
11. Kang L, He G, Sharp AK, et al. A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation [published online ahead of print, July 7 2021]. Cell 2021; S0092-8674:(21):00833–00833. doi: 10.1016/j.cell.2021.07.007 .
    [Google Scholar]
12. WHO. Tracking SARS-CoV-2 variants. Available from https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. Accessed August 2, 2021.
    [Google Scholar]
13. Konings F, Perkins MD, Kuhn JH, et al. SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse. Nat Microbiol 2021; 6:(7):821–823. doi: 10.1038/s41564-021-00932-w .
    [Google Scholar]
14. Burrell CJ, Howard CR, Murphy FA. Classification of viruses and phylogenetic relationships. Fenner White's Med Virol 2017:15–25. doi: 10.1016/B978-0-12-375156-0.00002-3 .
    [Google Scholar]
15. Rambaut A, Holmes EC, O'Toole Á, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol 2020; 5:(11):1403-1407. doi: 10.1038/s41564-020-0770-5 .
    [Google Scholar]
16. European Centre for Disease Prevention and Control. Threat assessment brief: emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA. Available from https://www.ecdc.europa.eu/en/publications-data/threat-assessment-emergence-sars-cov-2-b1617-variants. Accessed August 2, 2021.
17. Li Q, Wu J, Nie J, et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell 2020; 182:(5):1284–1294.e9.
    [Google Scholar]
18. CDC. SARS-CoV-2 variant classifications and definitions. Available from https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html. Accessed August 2, 2021.
    [Google Scholar]
19. Li B, Deng A, Li K, et al. Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. Available from https://www.medrxiv.org/content/10.1101/2021.07.07.21260122v2.full-text. Accessed July 29, 2021.
    [Google Scholar]
20. Achaiah NC, Subbarajasetty SB, Shetty RM. R₀ and R_e of COVID-19: can We Predict when the Pandemic Outbreak will be Contained? Indian J Crit Care Med 2020; 24:(11):1125–1127. doi: 10.5005/jp-journals-10071-23649 .
    [Google Scholar]
21. What we know about the SARS-CoV-2 Delta variant. Available from https://newsroom.unsw.edu.au/news/health/what-we-know-about-sars-cov-2-delta-variant. Accessed August 2, 2021. UNSW.
22. Gani R, Leach S. Transmission potential of smallpox in contemporary populations. Nature 2001; 414:(6865):748–751. doi: 10.1038/414748a .
    [Google Scholar]
23. Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant [published online ahead of print, July 21 2021]. N Engl J Med 2021; 385:(7):585–594. doi: 10.1056/NEJMoa2108891 .
    [Google Scholar]
24. The effects of virus variants on COVID-19 vaccines. Available from https://www.who.int/news-room/feature-stories/detail/the-effects-of-virus-variants-on-covid-19-vaccines?gclid=CjwKCAjwxo6IBhBKEiwAXSYBs4MWI6j9EmfBp8PvAJ0tCKavdWGqlc0Yucv7TL_bLiO3ZZWTr2B8rhoCGsUQAvD_BwE. Accessed July 30, 2021. World Health Organization.